ATRA — Atara Biotherapeutics Share News
0.000.00%
Last trade - 00:00- $86.22m
- $117.89m
- $120.77m
Brief: Atara Biotherapeutics Inc - On March 31, Entered Amendment To Commercialization Agreement With Pierre Fabre - SEC Filing
Brief: Atara Biotherapeutics Inc - Eric Hyllengren To Step Down As CFO And COO Of Atara Biotherapeutics - SEC Filing
Brief: Atara Biotherapeutics Inc To Cut 50% Of Workforce
Brief: Atara Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Netflix, Reddit, L3Harris
U.S. STOCKS ON THE MOVE-Prologis, Space stocks, Evolus
U.S. STOCKS ON THE MOVE-D.R. Horton, Moderna, Warner Bros Discovery
Atara Biotherapeutics falls after FDA puts clinical hold on cancer therapy trials
US FDA puts clinical hold on Atara's trials for cancer cell therapies (updated)
Brief: Atara Biotherapeutics Provides Update On Clinical Programs For Ebvallo™ And Ata3219
US FDA puts clinical hold on Atara's trials for cancer cell therapies
U.S. STOCKS ON THE MOVE-Freshworks, Flowco, Target
U.S. STOCKS ON THE MOVE-Southwest Airlines, Target, UnitedHealth
Atara Biotherapeutics slumps after FDA declines to approve cancer therapy
US FDA declines to approve Atara Biotherapeutics' cancer therapy (updated)
Brief: Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLOTM (tabelecleucel)
US FDA declines to approve Atara Biotherapeutics' cancer therapy
Atara Biotherapeutics Inc reports results for the quarter - Earnings Summary
Brief: Atara Biotherapeutics Q3 EPS USD -2.93